Biscayne Pharmaceuticals
Total Raised
$11.14MInvestors Count
5Deal Terms
1Funding, Valuation & Revenue
6 Fundings
Biscayne Pharmaceuticals has raised $11.14M over 6 rounds.
Biscayne Pharmaceuticals's latest funding round was a Series B for $3M on January 27, 2017.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
1/27/2017 | Series B | $3M | 3 | |||
11/4/2015 | Debt | |||||
10/5/2015 | Merger | |||||
1/11/2015 | Unattributed - II | |||||
5/1/2014 | Angel |
Date | 1/27/2017 | 11/4/2015 | 10/5/2015 | 1/11/2015 | 5/1/2014 |
|---|---|---|---|---|---|
Round | Series B | Debt | Merger | Unattributed - II | Angel |
Amount | $3M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 3 |
Biscayne Pharmaceuticals Deal Terms
1 Deal Term
Biscayne Pharmaceuticals's deal structure is available for 1 funding round, including their Series B from January 27, 2017.
Round | Series B |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B |
Biscayne Pharmaceuticals Investors
5 Investors
Biscayne Pharmaceuticals has 5 investors. Mesa Verde Venture Partners invested in Biscayne Pharmaceuticals's Series B funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
1/27/2017 | 1/27/2017 | 1 Series B | Venture Capital | California | ||
Venture Capital | Canada | |||||
Asset/Investment Management | China | |||||
Corporation | Florida | |||||
Non-Profit Foundation | Florida |
First funding | 1/27/2017 | ||||
|---|---|---|---|---|---|
Last Funding | 1/27/2017 | ||||
Investor | |||||
Rounds | 1 Series B | ||||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Asset/Investment Management | Corporation | Non-Profit Foundation |
Location | California | Canada | China | Florida | Florida |
Biscayne Pharmaceuticals Acquisitions
1 Acquisition
Biscayne Pharmaceuticals acquired 1 company. Their latest acquisition was Insero Health on October 05, 2015.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
10/5/2015 | Merger | 1 |
Date | 10/5/2015 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Merger |
Sources | 1 |
Loading...